693 related articles for article (PubMed ID: 28599652)
1. Regulatory T cells in multiple sclerosis and myasthenia gravis.
Danikowski KM; Jayaraman S; Prabhakar BS
J Neuroinflammation; 2017 Jun; 14(1):117. PubMed ID: 28599652
[TBL] [Abstract][Full Text] [Related]
2. Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells.
Aricha R; Reuveni D; Fuchs S; Souroujon MC
J Autoimmun; 2016 Feb; 67():57-64. PubMed ID: 26489998
[TBL] [Abstract][Full Text] [Related]
3. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.
Ma A; Xiong Z; Hu Y; Qi S; Song L; Dun H; Zhang L; Lou D; Yang P; Zhao Z; Wang X; Zhang D; Daloze P; Chen H
Int Immunopharmacol; 2009 May; 9(5):599-608. PubMed ID: 19539557
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines.
Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS
Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702
[TBL] [Abstract][Full Text] [Related]
5. Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model.
Gertel-Lapter S; Mizrachi K; Berrih-Aknin S; Fuchs S; Souroujon MC
Autoimmun Rev; 2013 Jul; 12(9):894-903. PubMed ID: 23535156
[TBL] [Abstract][Full Text] [Related]
6. C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.
Wang W; Milani M; Ostlie N; Okita D; Agarwal RK; Caspi RR; Conti-Fine BM
J Immunol; 2007 Jun; 178(11):7072-80. PubMed ID: 17513756
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis.
Aricha R; Feferman T; Fuchs S; Souroujon MC
J Immunol; 2008 Feb; 180(4):2132-9. PubMed ID: 18250419
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis.
Chae CS; Kwon HK; Hwang JS; Kim JE; Im SH
PLoS One; 2012; 7(12):e52119. PubMed ID: 23284891
[TBL] [Abstract][Full Text] [Related]
9. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.
Yang H; Zhang Y; Wu M; Li J; Zhou W; Li G; Li X; Xiao B; Christadoss P
Inflamm Res; 2010 Mar; 59(3):197-205. PubMed ID: 19768385
[TBL] [Abstract][Full Text] [Related]
10. Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis.
Thiruppathi M; Sheng JR; Li L; Prabhakar BS; Meriggioli MN
J Autoimmun; 2014 Aug; 52():64-73. PubMed ID: 24388113
[TBL] [Abstract][Full Text] [Related]
11. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
Front Immunol; 2018; 9():3119. PubMed ID: 30687323
[TBL] [Abstract][Full Text] [Related]
12. Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia.
Liu R; La Cava A; Bai XF; Jee Y; Price M; Campagnolo DI; Christadoss P; Vollmer TL; Van Kaer L; Shi FD
J Immunol; 2005 Dec; 175(12):7898-904. PubMed ID: 16339525
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis.
Souroujon MC; Aricha R; Feferman T; Mizrachi K; Reuveni D; Fuchs S
Ann N Y Acad Sci; 2012 Dec; 1274():120-6. PubMed ID: 23252906
[TBL] [Abstract][Full Text] [Related]
14. Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.
Aricha R; Mizrachi K; Fuchs S; Souroujon MC
J Autoimmun; 2011 Mar; 36(2):135-41. PubMed ID: 21193288
[TBL] [Abstract][Full Text] [Related]
15. BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO.
Kong QF; Sun B; Wang GY; Zhai DX; Mu LL; Wang DD; Wang JH; Li R; Li HL
Eur J Immunol; 2009 Mar; 39(3):800-9. PubMed ID: 19283707
[TBL] [Abstract][Full Text] [Related]
16. The role of regulatory T Cells in autoimmune orchitis.
Jacobo P
Andrologia; 2018 Dec; 50(11):e13092. PubMed ID: 30569653
[TBL] [Abstract][Full Text] [Related]
17. An angel or a devil? Current view on the role of CD8
Peng Y; Yang H; Chen Q; Jin H; Xue YH; Du MQ; Liu S; Yao SY
J Transl Med; 2024 Feb; 22(1):183. PubMed ID: 38378668
[TBL] [Abstract][Full Text] [Related]
18. IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.
Wang D; Ghosh D; Islam SM; Moorman CD; Thomason AE; Wilkinson DS; Mannie MD
J Immunol; 2016 Oct; 197(8):2992-3007. PubMed ID: 27619998
[TBL] [Abstract][Full Text] [Related]
19. Expansion of regulatory T cells via IL-2/anti-IL-2 mAb complexes suppresses experimental myasthenia.
Liu R; Zhou Q; La Cava A; Campagnolo DI; Van Kaer L; Shi FD
Eur J Immunol; 2010 Jun; 40(6):1577-89. PubMed ID: 20352624
[TBL] [Abstract][Full Text] [Related]
20. A Targeted Complement Inhibitor CRIg/FH Protects Against Experimental Autoimmune Myasthenia Gravis in Rats
Song J; Zhao R; Yan C; Luo S; Xi J; Ding P; Li L; Hu W; Zhao C
Front Immunol; 2022; 13():746068. PubMed ID: 35154091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
